The Extending the Cure project is a research and consultative effort that frames the growing problem of antibiotic resistance as a challenge in managing a shared societal resource.
Increased use of accurate rapid diagnostics tests (RDTs) has the potential to better target treatment as well as cut down on drug wastage. How can use of febrile illness RDTs be expanded in the developing world, and how can we measure the costs and benefits of doing so?
Pneumococcal diseases are responsible for an estimated 826,000 deaths of children under the age of five each year. PneuMOD models interventions to reduce the burden of pneumococcal infections worldwide.
Vitamin A deficiency is a serious public health issue in India. How could biofortification of mustard contribute to alleviating the problem?
If two drugs (in combination) are good, are three or more being used concurrently by different patients better at keeping drug resistance at bay?
The Affordable Medicines Facility – malaria (AMFm) is an innovative financing mechanism designed to expand access to the most effective treatment for malaria, artemisinin-based combination therapies (ACTs) through the public, private and NGO sectors.
In collaboration with the University of Washington, The Center for Global Health Research, and the Public Health Foundation of India, the Disease Control Priorities Network (DCPN) aims to improve the efficacy of health resource spending in various contexts around the globe.
The Malaria Atlas Project - Elimination (MAPe) is an international scientifi c collaboration with
close ties to the Malaria Atlas Project (MAP). The primary mission of MAPe is to develop a
strategic planning tool for malaria elimination. The strategic planning tool is being developed to
support country-level and international planning for malaria control and elimination using a linked
set of mathematical models and supporting databases.
The Global Antibiotic Resistance Partnership (GARP) will develop actionable policy proposals on antibiotic resistance for four low- and middle-income countries: India, Kenya, South Africa, and Vietnam. Proposals will identify weaknesses in how antibiotics are developed, regulated, and managed, and how well countries track antibiotic use and resistance.
